Common Contracts
17 similar Employment Agreement contracts by OptiNose, Inc.
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • March 8th, 2022 • OptiNose, Inc. • Pharmaceutical preparations • Delaware
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is entered into on March 2, 2022, by and between OptiNose US, Inc., a Delaware corporation (“OptiNose US”) and wholly-owned subsidiary of OptiNose, Inc. (the “Parent” and, together with OptiNose US, the “Company”), and Keith A. Goldan (“Executive”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • March 8th, 2022 • OptiNose, Inc. • Pharmaceutical preparations • Delaware
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is entered into on March 2, 2022, by and between OptiNose US, Inc., a Delaware corporation (“OptiNose US”) and wholly-owned subsidiary of OptiNose, Inc. (the “Parent” and, together with OptiNose US, the “Company”), and Dr. Ramy Mahmoud (“Executive”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • March 8th, 2022 • OptiNose, Inc. • Pharmaceutical preparations • Delaware
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is entered into on March 2, 2022, by and between OptiNose US, Inc., a Delaware corporation (“OptiNose US”) and wholly-owned subsidiary of OptiNose, Inc. (the “Parent” and, together with OptiNose US, the “Company”), and Peter K. Miller (“Executive”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • March 8th, 2022 • OptiNose, Inc. • Pharmaceutical preparations • Delaware
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is entered into on March 2, 2022, by and between OptiNose US, Inc., a Delaware corporation (“OptiNose US”) and wholly-owned subsidiary of OptiNose, Inc. (the “Parent” and, together with OptiNose US, the “Company”), and Michael F. Marino (“Executive”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • March 8th, 2022 • OptiNose, Inc. • Pharmaceutical preparations • Delaware
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is entered into on March 2, 2022, by and between OptiNose US, Inc., a Delaware corporation (“OptiNose US”) and wholly-owned subsidiary of OptiNose, Inc. (the “Parent” and, together with OptiNose US, the “Company”), and Victor M. Clavelli (“Executive”).
EX-10.2 5 a17-15165_17ex10d2.htm EX-10.2 EMPLOYMENT AGREEMENTEmployment Agreement • May 5th, 2020 • Delaware
This EMPLOYMENT AGREEMENT (the “Agreement”) is entered into on October 12, 2017, by and between OPTINOSE US, INC., a Delaware corporation (the “Company”), and Dr. Ramy Mahmoud (“Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • February 19th, 2020 • OptiNose, Inc. • Pharmaceutical preparations • Delaware
This EMPLOYMENT AGREEMENT (the “Agreement”) is entered into on February 17, 2020, (the “Effective Date”) by and between OPTINOSE US, INC., a Delaware corporation (the “Company”), and Victor M. Clavelli (“Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • October 18th, 2017 • OptiNose, Inc. • Pharmaceutical preparations • Delaware
This EMPLOYMENT AGREEMENT (the “Agreement”) is entered into on October 12, 2017, by and between OPTINOSE US, INC., a Delaware corporation (the “Company”), and Peter K. Miller (“Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • October 18th, 2017 • OptiNose, Inc. • Pharmaceutical preparations • Delaware
This EMPLOYMENT AGREEMENT (the “Agreement”) is entered into on October 12, 2017, by and between OPTINOSE US, INC., a Delaware corporation (the “Company”), and Keith A. Goldan (“Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • October 18th, 2017 • OptiNose, Inc. • Pharmaceutical preparations • Delaware
This EMPLOYMENT AGREEMENT (the “Agreement”) is entered into on October 12, 2017, by and between OPTINOSE US, INC., a Delaware corporation (the “Company”), and Thomas E. Gibbs (“Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • October 18th, 2017 • OptiNose, Inc. • Pharmaceutical preparations • Delaware
This EMPLOYMENT AGREEMENT (the “Agreement”) is entered into on October 12, 2017, by and between OPTINOSE US, INC., a Delaware corporation (the “Company”), and Dr. Ramy Mahmoud (“Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • October 18th, 2017 • OptiNose, Inc. • Pharmaceutical preparations • Delaware
This EMPLOYMENT AGREEMENT (the “Agreement”) is entered into on October 12, 2017, by and between OPTINOSE US, INC., a Delaware corporation (the “Company”), and Michael F. Marino (“Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • October 11th, 2017 • OptiNose, Inc. • Pharmaceutical preparations • Delaware
This EMPLOYMENT AGREEMENT (the “Agreement”) is entered into on October [ ], 2017, by and between OPTINOSE US, INC., a Delaware corporation (the “Company”), and Michael F. Marino (“Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • October 11th, 2017 • OptiNose, Inc. • Pharmaceutical preparations • Delaware
This EMPLOYMENT AGREEMENT (the “Agreement”) is entered into on October [ ], 2017, by and between OPTINOSE US, INC., a Delaware corporation (the “Company”), and Thomas E. Gibbs (“Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • October 11th, 2017 • OptiNose, Inc. • Pharmaceutical preparations • Delaware
This EMPLOYMENT AGREEMENT (the “Agreement”) is entered into on October , 2017, by and between OPTINOSE US, INC., a Delaware corporation (the “Company”), and Dr. Ramy Mahmoud (“Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • October 11th, 2017 • OptiNose, Inc. • Pharmaceutical preparations • Delaware
This EMPLOYMENT AGREEMENT (the “Agreement”) is entered into on October [ ], 2017, by and between OPTINOSE US, INC., a Delaware corporation (the “Company”), and Peter K. Miller (“Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • October 11th, 2017 • OptiNose, Inc. • Pharmaceutical preparations • Delaware
This EMPLOYMENT AGREEMENT (the “Agreement”) is entered into on October [ ], 2017, by and between OPTINOSE US, INC., a Delaware corporation (the “Company”), and Keith A. Goldan (“Executive”).
